38
Views
19
CrossRef citations to date
0
Altmetric
Original Article

The Effects of Orchidectomy, Estrogens, and Cyproterone Acetate on Plasma Testosterone, LH, and FSH Concentrations in Patients with Carcinoma of the Prostate

, &
Pages 31-36 | Received 02 Apr 1980, Published online: 15 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pavlos Msaouel, Evanthia Diamanti, Marinela Tzanela & Michael Koutsilieris. (2007) Luteinising hormone-releasing hormone antagonists in prostate cancer therapy. Expert Opinion on Emerging Drugs 12:2, pages 285-299.
Read now
Lyndon M Gommersall, Dickon Hayne, Iqbal S Shergill, Manit Arya & DMA Wallace. (2002) Luteinising hormone releasing hormone analogues in the treatment of prostate cancer. Expert Opinion on Pharmacotherapy 3:12, pages 1685-1692.
Read now

Articles from other publishers (17)

Alyssa K. Greiman & Thomas E. Keane. (2017) Approach to Androgen Deprivation in the Prostate Cancer Patient with Pre-existing Cardiovascular Disease. Current Urology Reports 18:6.
Crossref
Imran Masood, Maria H. Kiani, Mahmood Ahmad, Muhammed I. Masood & Hadia Sadaquat. (2015) Major Contributions towards Finding a Cure for Cancer through Chemotherapy: A Historical Review. Tumori Journal 102:1, pages 6-17.
Crossref
N D Shore, P-A Abrahamsson, J Anderson, E D Crawford & P Lange. (2012) New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists. Prostate Cancer and Prostatic Diseases 16:1, pages 7-15.
Crossref
Teuvo L.J. Tammela. (2012) Endocrine prevention and treatment of prostate cancer. Molecular and Cellular Endocrinology 360:1-2, pages 59-67.
Crossref
Sasa Vojinov, Ivan Levakov, Dimitrije Jeremic, Srdjan Zivojinov & Goran Marusic. (2011) Hormonal status in patients with advanced prostatic cancer on the therapy with androgen blockade. Vojnosanitetski pregled Military Medical and Pharmaceutical Journal of Serbia 68:4, pages 321-326.
Crossref
Fritz H. Schröder & Albert Radlmaier. 2009. Hormone Therapy in Breast and Prostate Cancer. Hormone Therapy in Breast and Prostate Cancer 325 346 .
Chandan Kumar-Sinha, Scott A. Tomlins & Arul M. Chinnaiyan. (2008) Recurrent gene fusions in prostate cancer. Nature Reviews Cancer 8:7, pages 497-511.
Crossref
Teuvo Tammela. (2004) Endocrine treatment of prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 92:4, pages 287-295.
Crossref
Samuel R. Denmeade & John T. Isaacs. (2004) Development of prostate cancer treatment: The good news. The Prostate 58:3, pages 211-224.
Crossref
Tomasz M Beer, Mark Garzotto, Kristi M Eilers, Dianne Lemmon & Emily M Wersinger. (2004) Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy. Urology 63:2, pages 342-347.
Crossref
TOMASZ M. BEER, MARK GARZOTTO, KRISTI M. EILERS & DIANNE LEMMON. (2003) Phase II Study of Abarelix Depot for Androgen Independent Prostate Cancer Progression During Gonadotropin-Releasing Hormone Agonist Therapy. Journal of Urology 169:5, pages 1738-1741.
Crossref
Samuel R. Denmeade & John T. Isaacs. (2002) A history of prostate cancer treatment. Nature Reviews Cancer 2:5, pages 389-396.
Crossref
RS Kirby. (1996) RECENT ADVANCES IN THE MEDICAL MANAGEMENT OF PROSTATE CANCER. International Journal of Clinical Practice 50:2, pages 88-93.
Crossref
C.R. Charig & J.S. Rundle. (1989) Flushing long-term side effect of orchiectomy in treatment of prostatic carcinoma. Urology 33:3, pages 175-178.
Crossref
Victoria Clos, Asunción Esteve, Francisco Jane & Pablo Salva. (1988) Microsomal effects of cyproterone acetate and flutamide in rat testis. General Pharmacology: The Vascular System 19:3, pages 393-397.
Crossref
Paul Jungers, Frédérique Kuttenn, Frédéric Liote, Clara Pelissier, Nicole Athea, Marie‐Christine Laurent, Joëlle Viriot, Maxime Dougados & Jean‐François Bach. (2005) Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate. Arthritis & Rheumatism 28:11, pages 1243-1250.
Crossref
P. O. Hedlund, D. Freedman, P. Esposti, S. Gershagen & K. Carlström. (1985) High-dose danazol therapy in prostatic cancer patients: Endocrine and clinical effects. The Prostate 7:4, pages 347-356.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.